-
1
-
-
0023236055
-
The nerve growth factor 35 years later
-
Levi Montalcini R. The nerve growth factor 35 years later. Science 1987;237:1154-62.
-
(1987)
Science
, vol.237
, pp. 1154-62
-
-
Levi Montalcini, R.1
-
2
-
-
0346849773
-
NGF and related molecules in health and disease
-
Aloe L, Calzà, L (Eds.). NGF and related molecules in health and disease. Progr Brain Res 2004;146.
-
(2004)
Progr Brain Res
, vol.146
-
-
Aloe, L.1
Calzà, L.2
-
3
-
-
0024596711
-
Effect of NGF on the survival of rat retinal ganglion cells following optic nerve section
-
Carmignoto G, Maffei L, Candeo P, Canella R, Comelli C. Effect of NGF on the survival of rat retinal ganglion cells following optic nerve section. J Neurosci 1989;9:1263-72.
-
(1989)
J Neurosci
, vol.9
, pp. 1263-1262
-
-
Carmignoto, G.1
Maffei, L.2
Candeo, P.3
Canella, R.4
Comelli, C.5
-
4
-
-
0026766860
-
The nerve growth factor family of receptors
-
Meakin SO, Shooter EM. The nerve growth factor family of receptors. Trends Neurosci 1992;15:323-31.
-
(1992)
Trends Neurosci
, vol.15
, pp. 323-331
-
-
Meakin, S.O.1
Shooter, E.M.2
-
5
-
-
0032102110
-
The role of neuronal growth factors in neurodegenerative disorders of the human brain
-
DOI 10.1016/S0165-0173(98)00004-6, PII S0165017398000046
-
Connor B, Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Rev 1998;27:1-39. (Pubitemid 28300281)
-
(1998)
Brain Research Reviews
, vol.27
, Issue.1
, pp. 1-39
-
-
Connor, B.1
Dragunow, M.2
-
6
-
-
11844256387
-
Diabetes mellitus as a risk factor for glaucomatous optic neuropathy
-
DOI 10.1159/000081775
-
Nakamura M, Kanamori A, Negi A. Diabetes mellitus as a risk factor for glaucomatous optic neuropathy. Ophthalmologica 2005;219:1-10. (Pubitemid 40091383)
-
(2005)
Ophthalmologica
, vol.219
, Issue.1
, pp. 1-10
-
-
Nakamura, M.1
Kanamori, A.2
Negi, A.3
-
7
-
-
77955865169
-
Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes
-
van Dijk HW, Verbraak FD, Kok PH, Garvin MK, Sonka M, Lee K, Devries JH, Michels RP, van Velthoven ME, Schlingemann RO, Abràmoff MD. Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes. Invest Ophthalmol Vis Sci 2010;51:3660-5.
-
(2010)
Invest Ophthalmol Vis Sci
, vol.51
, pp. 3660-3665
-
-
Van Dijk, H.W.1
Verbraak, F.D.2
Kok, P.H.3
Garvin, M.K.4
Sonka, M.5
Lee, K.6
Devries, J.H.7
Michels, R.P.8
Van Velthoven, M.E.9
Schlingemann, R.O.10
Abràmoff, M.D.11
-
8
-
-
0024587287
-
Intraocular pressure and glaucoma
-
Sommer A. Intraocular pressure and glaucoma. Am J Ophthalmol 1989;107:186-8. (Pubitemid 19049847)
-
(1989)
American Journal of Ophthalmology
, vol.107
, Issue.2
, pp. 186-188
-
-
Sommer, A.1
-
9
-
-
34848907420
-
Overview of epidemiologic studies of diabetic retinopathy
-
DOI 10.1080/09286580701396720, PII 782472822
-
Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 2007;14:179-83. (Pubitemid 47493723)
-
(2007)
Ophthalmic Epidemiology
, vol.14
, Issue.4
, pp. 179-183
-
-
Klein, B.E.K.1
-
10
-
-
0026462896
-
Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light
-
LaVail MM, Unoki K, Yasumura D, Matthes MT, Yancopoulos GD, Steinberg RH. Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc Natl Acad Sci USA 1992;89:11249-53.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 11249-11253
-
-
LaVail, M.M.1
Unoki, K.2
Yasumura, D.3
Matthes, M.T.4
Yancopoulos, G.D.5
Steinberg, R.H.6
-
12
-
-
34547702738
-
Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury
-
DOI 10.2353/ajpath.2007.061237
-
Nishijima K, Ng YS, Zhong L, et al. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol 2007;171:53-67. (Pubitemid 47339226)
-
(2007)
American Journal of Pathology
, vol.171
, Issue.1
, pp. 53-67
-
-
Nishijima, K.1
Ng, Y.-S.2
Zhong, L.3
Bradley, J.4
Schubert, W.5
Jo, N.6
Akita, J.7
Samuelsson, S.J.8
Robinson, G.S.9
Adamis, A.P.10
Shima, D.T.11
-
13
-
-
0033565417
-
Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system
-
Sondell M, Lundborg G, Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci 1999;19:5731-40. (Pubitemid 29327910)
-
(1999)
Journal of Neuroscience
, vol.19
, Issue.14
, pp. 5731-5740
-
-
Sondell, M.1
Lundborg, G.2
Kanje, M.3
-
14
-
-
56149103354
-
Endogenous VEGF is required for visual function: Evidence for a survival role on muller cells and photoreceptors
-
Saint-Geniez M, Maharaj AS, Walshe TE, et al. Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors. PLoS ONE 2008;3: e3554-60.
-
(2008)
PLoS ONE
, vol.3
-
-
Saint-Geniez, M.1
Maharaj, A.S.2
Walshe, T.E.3
-
15
-
-
56049120307
-
Retinal p75 and bax overexpression is associated with retinal ganglion cells apoptosis in a rat model of glaucoma
-
Coassin M, Lambiase A, Sposato V, Micera A, Bonini S, Aloe L. Retinal p75 and bax overexpression is associated with retinal ganglion cells apoptosis in a rat model of glaucoma. Graefes Arch Clin Exp Ophthalmol 2008;246:1743-9.
-
(2008)
Graefes Arch Clin Exp Ophthalmol
, vol.246
, pp. 1743-1749
-
-
Coassin, M.1
Lambiase, A.2
Sposato, V.3
Micera, A.4
Bonini, S.5
Aloe, L.6
-
16
-
-
57049118997
-
Glaucoma alters the expression of NGF and NGF receptors in visual cortex and geniculate nucleus of rats: Effect of eye NGF application
-
Sposato V, Parisi V, Manni L, et al. Glaucoma alters the expression of NGF and NGF receptors in visual cortex and geniculate nucleus of rats: effect of eye NGF application. Vision Res 2009;49:54-63.
-
(2009)
Vision Res
, vol.49
, pp. 54-63
-
-
Sposato, V.1
Parisi, V.2
Manni, L.3
-
17
-
-
53549116427
-
Reduced NGF level and TrkA protein and TrkA gene expression in the optic nerve of rats with experimentally induced glaucoma
-
Sposato V, Bucci MG, Coassin M, Russo MA, Lambiase A, Aloe L. Reduced NGF level and TrkA protein and TrkA gene expression in the optic nerve of rats with experimentally induced glaucoma. Neurosci Lett 2008;446:20-4.
-
(2008)
Neurosci Lett
, vol.446
, pp. 20-24
-
-
Sposato, V.1
Bucci, M.G.2
Coassin, M.3
Russo, M.A.4
Lambiase, A.5
Aloe, L.6
-
18
-
-
0030730372
-
Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension
-
Lambiase A, Centofanti M, Micera A, et al. Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension. Graefes Arch Clin Exp Ophthalmol 1997;235:780-5. (Pubitemid 27514275)
-
(1997)
Graefe's Archive for Clinical and Experimental Ophthalmology
, vol.235
, Issue.12
, pp. 780-785
-
-
Lambiase, A.1
Centofanti, M.2
Micera, A.3
Manni, G.L.4
Mattei, E.5
De Gregorio, A.6
De Feo, G.7
Bucci, M.G.8
Aloe, L.9
-
19
-
-
15244345579
-
Effect of exogenous administration of nerve growth factor in the retina of rats with inherited retinitis pigmentosa
-
DOI 10.1016/j.visres.2004.12.020
-
Lenzi L, Coassin M, Lambiase A, Bonini S, Amendola T, Aloe L. Effect of exogenous administration of nerve growth factor in the retina of rats with inherited retinitis pigmentosa. Vision Res 2005;45:1491-500. (Pubitemid 40386723)
-
(2005)
Vision Research
, vol.45
, Issue.12
, pp. 1491-1500
-
-
Lenzi, L.1
Coassin, M.2
Lambiase, A.3
Bonini, S.4
Amendola, T.5
Aloe, L.6
-
20
-
-
69449091997
-
Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma
-
Lambiase A, Aloe L, Centofanti M, et al. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma. Proc Natl Acad Sci USA 2009;106:13469-74.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 13469-13474
-
-
Lambiase, A.1
Aloe, L.2
Centofanti, M.3
-
21
-
-
73849104545
-
Nerve Growth Factor eye drops improve visual acuity and electrofunctional activity in age related macular degeneration: A case report
-
Lambiase A, Coassin M, Tirassa P, Mantelli F, Aloe L. Nerve Growth Factor eye drops improve visual acuity and electrofunctional activity in age related macular degeneration: a case report. Ann Ist Super Sanità 2009;45:439-42.
-
(2009)
Ann Ist Super Sanità
, vol.45
, pp. 439-442
-
-
Lambiase, A.1
Coassin, M.2
Tirassa, P.3
Mantelli, F.4
Aloe, L.5
-
22
-
-
77955865169
-
Decreased retinal ganglion cell layer thickness in type 1 diabetic patients Van Dijk
-
Van Dijk HW, Verbraak FD, Kok PH, Garvin MK, Sonka M, Lee K, Devries JH, Michels RP, van Velthoven ME, Schlingemann RO, Abramoff MD. Decreased retinal ganglion cell layer thickness in type 1 diabetic patients. Van Dijk. Invest Ophthalmol Vis Sci 2010;51:3660-5.
-
(2010)
Invest Ophthalmol Vis Sci
, vol.51
, pp. 3660-3665
-
-
Van Dijk, H.W.1
Verbraak, F.D.2
Kok, P.H.3
Garvin, M.K.4
Sonka, M.5
Lee, K.6
Devries, J.H.7
Michels, R.P.8
Van Velthoven, M.E.9
Schlingemann, R.O.10
Abramoff, M.D.11
-
23
-
-
0031039243
-
The biology of vascular endothelial growth factor
-
DOI 10.1210/er.18.1.4
-
Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25. (Pubitemid 27076453)
-
(1997)
Endocrine Reviews
, vol.18
, Issue.1
, pp. 4-25
-
-
Ferrara, N.1
Davis-Smyth, T.2
-
24
-
-
33745740520
-
Cross talk between the cardiovascular and nervous systems: Neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development
-
Lazarovici P, Marcinkiewicz C, Lelkes PI. Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development. Curr Pharm Des 2006;12:2609-22.
-
(2006)
Curr Pharm Des
, vol.12
, pp. 2609-2622
-
-
Lazarovici, P.1
Marcinkiewicz, C.2
Lelkes, P.I.3
-
25
-
-
39149134314
-
Nerve growth factor as an angiogenic factor
-
DOI 10.1016/j.mvr.2007.07.004, PII S002628620700088X
-
Nico B, Mangieri D, Benagiano V, Crivellato E, Ribatti D. Nerve growth factor as an angiogenic factor. Microvascular Res 2008;75:135-41. (Pubitemid 351249859)
-
(2008)
Microvascular Research
, vol.75
, Issue.2
, pp. 135-141
-
-
Nico, B.1
Mangieri, D.2
Benagiano, V.3
Crivellato, E.4
Ribatti, D.5
-
26
-
-
0031029858
-
A rat model of chronic pressure-induced optic nerve damage
-
DOI 10.1006/exer.1996.0184
-
Morrison JC, Moore CG, Deppmeier LM, Gold BG, Meshul CK, Johnson EC. A rat model of chronic pressure-induced optic nerve damage. Exp Eye Res 1997:64:85-96. (Pubitemid 27096643)
-
(1997)
Experimental Eye Research
, vol.64
, Issue.1
, pp. 85-96
-
-
Morrison, J.C.1
Moore, C.G.2
Deppmeier, L.M.H.3
Gold, B.G.4
Meshul, C.K.5
Johnson, E.C.6
-
27
-
-
0029331089
-
Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes
-
Hammes HP, Federoff HJ, Brownlee M. Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med 1995:1:527-34.
-
(1995)
Mol Med
, vol.1
, pp. 527-534
-
-
Hammes, H.P.1
Federoff, H.J.2
Brownlee, M.3
-
28
-
-
0014584518
-
The nerve growth factor: Purification as a 30,000-molecular-weight protein
-
Bocchini V, Angeletti PU. The nerve growth factor: purification as a 30,000-molecular-weight protein. Proc Natl Acad Sci USA 1969;64:787-94.
-
(1969)
Proc Natl Acad Sci USA
, vol.64
, pp. 787-794
-
-
Bocchini, V.1
Angeletti, P.U.2
-
29
-
-
0017129438
-
Purification of nerve growth factor antibodies by affinity chromatography
-
Stoeckel K, Gagnon C, Guroff G, Thoenen H. Purification of nerve growth factor antibodies by affinity chromatography. J Neurochem 1976;26:1207-11.
-
(1976)
J Neurochem
, vol.26
, pp. 1207-1211
-
-
Stoeckel, K.1
Gagnon, C.2
Guroff, G.3
Thoenen, H.4
-
30
-
-
0027942607
-
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
-
DOI 10.1056/NEJM199412013312203
-
Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-7. (Pubitemid 24356306)
-
(1994)
New England Journal of Medicine
, vol.331
, Issue.22
, pp. 1480-1487
-
-
Aiello, L.P.1
Avery, R.L.2
Arrigg, P.G.3
Keyt, B.A.4
Jampel, H.D.5
Shah, S.T.6
Pasquale, L.R.7
Thieme, H.8
Iwamoto, M.A.9
Park, J.E.10
Nguyen, H.V.11
Aiello, L.M.12
Ferrara, N.13
King, G.L.14
-
31
-
-
0027970291
-
Nerve growth factor reduces apoptosis of axotomized retinal ganglion cells in the neonatal rat
-
DOI 10.1016/0306-4522(94)90565-7
-
Rabacchi SA, Ensini M, Bonfanti L, Gravina A, Maffei L. Nerve growth factor reduces apoptosis of axotomized retinal ganglion cells in the neonatal rat. Neuroscience 1994;63:969-73. (Pubitemid 24366148)
-
(1994)
Neuroscience
, vol.63
, Issue.4
, pp. 969-973
-
-
Rabacchi, S.A.1
Ensini, M.2
Bonfanti, L.3
Gravina, A.4
Maffei, L.5
-
32
-
-
0027522462
-
Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo
-
DOI 10.1016/0006-8993(93)90695-J
-
Mey J, Thanos S Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res 1993;602:304-17. (Pubitemid 23053202)
-
(1993)
Brain Research
, vol.602
, Issue.2
, pp. 304-317
-
-
Mey, J.1
Thanos, S.2
-
33
-
-
0034031474
-
Diffusion of high molecular weight compounds through sclera
-
Ambati J, Canakis CS, Miller JW, et al. Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci 2000;41:1181-5. (Pubitemid 30187558)
-
(2000)
Investigative Ophthalmology and Visual Science
, vol.41
, Issue.5
, pp. 1181-1185
-
-
Ambati, J.1
Canakis, C.S.2
Miller, J.W.3
Gragoudas, E.S.4
Edwards, A.5
Weissgold, D.J.6
Kim, I.7
Delori, F.C.8
Adamis, A.P.9
-
34
-
-
0038136601
-
Pharmacokinetics of topical ocular drug delivery: Potential uses for the treatment of diseases of the posterior segment and beyond
-
DOI 10.2174/1389200033489488
-
Koevary SB. Pharmacokinetics of topical ocular drug delivery: potential uses for the treatment of diseases of the posterior segment and beyond. Curr Drug Metab 2003;4:213-22. (Pubitemid 36656479)
-
(2003)
Current Drug Metabolism
, vol.4
, Issue.3
, pp. 213-222
-
-
Koevary, S.B.1
-
35
-
-
23044497405
-
Retinal ganglion cell death in glaucoma: Mechanisms and neuroprotective strategies
-
DOI 10.1016/j.ohc.2005.04.002, PII S0896154905000428, Glaucoma
-
Kuehn MH, Fingert JH, Kwon YH Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies. Ophthalmol Clin North Am 2005;18:383-95. (Pubitemid 41073864)
-
(2005)
Ophthalmology Clinics of North America
, vol.18
, Issue.3
, pp. 383-395
-
-
Kuehn, M.H.1
Fingert, J.H.2
Kwon, Y.H.3
-
36
-
-
22544479099
-
Lessons for glaucoma from other neurodegenerative diseases: Can one treatment suit them all?
-
DOI 10.1097/01.ijg.0000169412.86387.ad
-
Schwartz M. Lessons for glaucoma from other neurodegenerative diseases: can one treatment suit them all? J Glaucoma 2005;14:321-3. (Pubitemid 41023022)
-
(2005)
Journal of Glaucoma
, vol.14
, Issue.4
, pp. 321-323
-
-
Schwartz, M.1
|